Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis
Anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) are the most commonly used diagnostic markers of rheumatoid arthritis (RA). These antibodies are predominantly of the immunoglobulin (Ig) M (RF) or IgG (ACPA) isotype. Other subtypes of both antibodies-particularly IgA isotypes...
Saved in:
Published in | Frontiers in Immunology Vol. 9; p. 876 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media SA
24.04.2018
Frontiers Media S.A |
Subjects | |
Online Access | Get full text |
ISSN | 1664-3224 1664-3224 |
DOI | 10.3389/fimmu.2018.00876 |
Cover
Abstract | Anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) are the most commonly used diagnostic markers of rheumatoid arthritis (RA). These antibodies are predominantly of the immunoglobulin (Ig) M (RF) or IgG (ACPA) isotype. Other subtypes of both antibodies-particularly IgA isotypes and other autoantibodies-such as RA33 antibodies-have been repeatedly reported but their diagnostic value has still not been fully elucidated. Here, we investigated the prevalence of IgA, IgG, and IgM subtypes of RF, ACPA, and RA33 antibodies in patients with RA. To determine the diagnostic specificity and sensitivity sera from 290 RA patients (165 early and 125 established disease), 261 disease controls and 100 healthy subjects were tested for the presence of IgA, IgG, and IgM isotypes of RF, ACPA, and RA33 by EliA™ platform (Phadia AB, Uppsala, Sweden). The most specific antibodies were IgG-ACPA, IgA-ACPA, and IgG-RF showing specificities >98%, closely followed by IgG- and IgA-RA33 while IgM subtypes were somewhat less specific, ranging from 95.8% (RA33) to 90% (RF). On the other hand, IgM-RF was the most sensitive subtype (65%) followed by IgG-ACPA (59.5%) and IgA-RF (50.7%). Other subtypes were less sensitive ranging from 35 (IgA-ACPA) to 6% (IgA-RA33). RA33 antibodies as well as IgA-RF and IgA-ACPA were found to increase the diagnostic sensitivity of serological testing since they were detected also in seronegative patients reducing their number from 109 to 85. Moreover, analyzing IgM-RF by EliA™ proved more sensitive than measuring RF by nephelometry and further reduced the number of seronegative patients to 76 individuals. Importantly, among antibody positive individuals, RA patients were found having significantly more antibodies (≥3) than disease controls which generally showed one or two antibody species. Thus, increasing the number of autoantibodies in serological routine testing provides valuable additional information allowing to better distinguish between RA and other rheumatic disorders, also in patients not showing antibodies in current routine diagnostics. In conclusion, testing for multiple autoantibody specificities increases the diagnostic power of autoimmune diagnostics and could further support physicians in clinical decision-making. |
---|---|
AbstractList | Anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) are the most commonly used diagnostic markers of rheumatoid arthritis (RA). These antibodies are predominantly of the immunoglobulin (Ig) M (RF) or IgG (ACPA) isotype. Other subtypes of both antibodies-particularly IgA isotypes and other autoantibodies-such as RA33 antibodies-have been repeatedly reported but their diagnostic value has still not been fully elucidated. Here, we investigated the prevalence of IgA, IgG, and IgM subtypes of RF, ACPA, and RA33 antibodies in patients with RA. To determine the diagnostic specificity and sensitivity sera from 290 RA patients (165 early and 125 established disease), 261 disease controls and 100 healthy subjects were tested for the presence of IgA, IgG, and IgM isotypes of RF, ACPA, and RA33 by EliA™ platform (Phadia AB, Uppsala, Sweden). The most specific antibodies were IgG-ACPA, IgA-ACPA, and IgG-RF showing specificities >98%, closely followed by IgG- and IgA-RA33 while IgM subtypes were somewhat less specific, ranging from 95.8% (RA33) to 90% (RF). On the other hand, IgM-RF was the most sensitive subtype (65%) followed by IgG-ACPA (59.5%) and IgA-RF (50.7%). Other subtypes were less sensitive ranging from 35 (IgA-ACPA) to 6% (IgA-RA33). RA33 antibodies as well as IgA-RF and IgA-ACPA were found to increase the diagnostic sensitivity of serological testing since they were detected also in seronegative patients reducing their number from 109 to 85. Moreover, analyzing IgM-RF by EliA™ proved more sensitive than measuring RF by nephelometry and further reduced the number of seronegative patients to 76 individuals. Importantly, among antibody positive individuals, RA patients were found having significantly more antibodies (≥3) than disease controls which generally showed one or two antibody species. Thus, increasing the number of autoantibodies in serological routine testing provides valuable additional information allowing to better distinguish between RA and other rheumatic disorders, also in patients not showing antibodies in current routine diagnostics. In conclusion, testing for multiple autoantibody specificities increases the diagnostic power of autoimmune diagnostics and could further support physicians in clinical decision-making.Anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) are the most commonly used diagnostic markers of rheumatoid arthritis (RA). These antibodies are predominantly of the immunoglobulin (Ig) M (RF) or IgG (ACPA) isotype. Other subtypes of both antibodies-particularly IgA isotypes and other autoantibodies-such as RA33 antibodies-have been repeatedly reported but their diagnostic value has still not been fully elucidated. Here, we investigated the prevalence of IgA, IgG, and IgM subtypes of RF, ACPA, and RA33 antibodies in patients with RA. To determine the diagnostic specificity and sensitivity sera from 290 RA patients (165 early and 125 established disease), 261 disease controls and 100 healthy subjects were tested for the presence of IgA, IgG, and IgM isotypes of RF, ACPA, and RA33 by EliA™ platform (Phadia AB, Uppsala, Sweden). The most specific antibodies were IgG-ACPA, IgA-ACPA, and IgG-RF showing specificities >98%, closely followed by IgG- and IgA-RA33 while IgM subtypes were somewhat less specific, ranging from 95.8% (RA33) to 90% (RF). On the other hand, IgM-RF was the most sensitive subtype (65%) followed by IgG-ACPA (59.5%) and IgA-RF (50.7%). Other subtypes were less sensitive ranging from 35 (IgA-ACPA) to 6% (IgA-RA33). RA33 antibodies as well as IgA-RF and IgA-ACPA were found to increase the diagnostic sensitivity of serological testing since they were detected also in seronegative patients reducing their number from 109 to 85. Moreover, analyzing IgM-RF by EliA™ proved more sensitive than measuring RF by nephelometry and further reduced the number of seronegative patients to 76 individuals. Importantly, among antibody positive individuals, RA patients were found having significantly more antibodies (≥3) than disease controls which generally showed one or two antibody species. Thus, increasing the number of autoantibodies in serological routine testing provides valuable additional information allowing to better distinguish between RA and other rheumatic disorders, also in patients not showing antibodies in current routine diagnostics. In conclusion, testing for multiple autoantibody specificities increases the diagnostic power of autoimmune diagnostics and could further support physicians in clinical decision-making. Anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) are the most commonly used diagnostic markers of rheumatoid arthritis (RA). These antibodies are predominantly of the immunoglobulin (Ig) M (RF) or IgG (ACPA) isotype. Other subtypes of both antibodies—particularly IgA isotypes and other autoantibodies—such as RA33 antibodies—have been repeatedly reported but their diagnostic value has still not been fully elucidated. Here, we investigated the prevalence of IgA, IgG, and IgM subtypes of RF, ACPA, and RA33 antibodies in patients with RA. To determine the diagnostic specificity and sensitivity sera from 290 RA patients (165 early and 125 established disease), 261 disease controls and 100 healthy subjects were tested for the presence of IgA, IgG, and IgM isotypes of RF, ACPA, and RA33 by EliA™ platform (Phadia AB, Uppsala, Sweden). The most specific antibodies were IgG-ACPA, IgA-ACPA, and IgG-RF showing specificities >98%, closely followed by IgG- and IgA-RA33 while IgM subtypes were somewhat less specific, ranging from 95.8% (RA33) to 90% (RF). On the other hand, IgM-RF was the most sensitive subtype (65%) followed by IgG-ACPA (59.5%) and IgA-RF (50.7%). Other subtypes were less sensitive ranging from 35 (IgA-ACPA) to 6% (IgA-RA33). RA33 antibodies as well as IgA-RF and IgA-ACPA were found to increase the diagnostic sensitivity of serological testing since they were detected also in seronegative patients reducing their number from 109 to 85. Moreover, analyzing IgM-RF by EliA™ proved more sensitive than measuring RF by nephelometry and further reduced the number of seronegative patients to 76 individuals. Importantly, among antibody positive individuals, RA patients were found having significantly more antibodies (≥3) than disease controls which generally showed one or two antibody species. Thus, increasing the number of autoantibodies in serological routine testing provides valuable additional information allowing to better distinguish between RA and other rheumatic disorders, also in patients not showing antibodies in current routine diagnostics. In conclusion, testing for multiple autoantibody specificities increases the diagnostic power of autoimmune diagnostics and could further support physicians in clinical decision-making. |
Author | Sascha; Horn Sieghart Helmuth; Blueml Alexander; Studenic Josef; Steiner Daniela; Platzer Maresa; Swiniarski Paul; Alasti Thomas; Haslacher Stephan; Smolen Farideh; Grundhuber Guenter |
AuthorAffiliation | 2 Thermo Fisher Scientific, Phadia GmbH , Freiburg , Germany 1 Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna , Vienna , Austria 3 Thermo Fisher Scientific, Phadia Austria GmbH , Vienna , Austria 4 Department of Laboratory Medicine, Medical University of Vienna , Vienna , Austria |
AuthorAffiliation_xml | – name: 4 Department of Laboratory Medicine, Medical University of Vienna , Vienna , Austria – name: 1 Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna , Vienna , Austria – name: 2 Thermo Fisher Scientific, Phadia GmbH , Freiburg , Germany – name: 3 Thermo Fisher Scientific, Phadia Austria GmbH , Vienna , Austria |
Author_xml | – sequence: 1 givenname: Daniela surname: Sieghart fullname: Sieghart, Daniela – sequence: 2 givenname: Alexander surname: Platzer fullname: Platzer, Alexander – sequence: 3 givenname: Paul surname: Studenic fullname: Studenic, Paul – sequence: 4 givenname: Farideh surname: Alasti fullname: Alasti, Farideh – sequence: 5 givenname: Maresa surname: Grundhuber fullname: Grundhuber, Maresa – sequence: 6 givenname: Sascha surname: Swiniarski fullname: Swiniarski, Sascha – sequence: 7 givenname: Thomas surname: Horn fullname: Horn, Thomas – sequence: 8 givenname: Helmuth surname: Haslacher fullname: Haslacher, Helmuth – sequence: 9 givenname: Stephan surname: Blüml fullname: Blüml, Stephan – sequence: 10 givenname: Josef surname: Smolen fullname: Smolen, Josef – sequence: 11 givenname: Günter surname: Steiner fullname: Steiner, Günter |
BackLink | https://cir.nii.ac.jp/crid/1871147691292693120$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/29740454$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UktvEzEQtlARLaF3TmgPHLgkjN_rC1JUXpEqIVE4W95db-KyawfbWyn_Hm_SopYDPtij8XwPab6X6MwHbxF6jWFFaa3e924cpxUBXK8AaimeoQssBFtSQtjZo_ocXaZ0C-UwRSnlL9A5UZIB4-wC_fpos42j8ya74KvQV-spB-Oza0J3qDYp5MPepmrj22hNKlXe2erG-uSyu3P5MENubAydM1sfUnZtqpyvvu_sNJocXFetY97FMp1eoee9GZK9vH8X6OfnTz-uvi6vv33ZXK2vly3nMi8lxtATRoQkllPAAMLWvcK0abghBCxA00sCvKulAdHhvmFgJKEcGlIrRRdoc-LtgrnV--hGEw86GKePjRC32sRidLCaWw6yrqXCnWSESMMYE50BTBUozGTh-nDi2k_NaLvW-hzN8IT06Y93O70Nd5orUghmM-_uCWL4PdmU9ehSa4fBeBumpAlQIWtJiv8FevNY66_Iw7bKgDgNtDGkFG2vW5ePiyvSbtAY9JwMfUyGnpOhj8koQPgH-MD9H8jbE8Q7V2TmG9dlNUwKhYkiQlFcvP8BgnvGjw |
CitedBy_id | crossref_primary_10_3389_fimmu_2022_1096866 crossref_primary_10_1016_j_chest_2020_04_075 crossref_primary_10_1136_rmdopen_2022_002705 crossref_primary_10_1016_j_plabm_2024_e00420 crossref_primary_10_3390_ijms24043321 crossref_primary_10_1515_cclm_2022_0411 crossref_primary_10_3390_molecules27041452 crossref_primary_10_1515_cclm_2023_0109 crossref_primary_10_1016_j_clinbiochem_2020_05_019 crossref_primary_10_1080_10408363_2020_1775545 crossref_primary_10_1080_14737159_2023_2247986 crossref_primary_10_1093_rheumatology_keae297 crossref_primary_10_1136_ard_2023_223901 crossref_primary_10_1136_rmdopen_2022_002817 crossref_primary_10_1371_journal_pone_0290793 crossref_primary_10_1080_03009742_2020_1713395 crossref_primary_10_1515_cclm_2022_0244 crossref_primary_10_47360_1995_4484_2023_276_291 crossref_primary_10_23736_S1825_859X_21_00114_6 crossref_primary_10_1038_s41598_019_56279_0 crossref_primary_10_1186_s13075_020_02191_2 crossref_primary_10_1007_s10787_022_01035_6 crossref_primary_10_1093_jalm_jfab132 crossref_primary_10_1007_s10067_021_05814_4 crossref_primary_10_3389_fimmu_2021_651049 crossref_primary_10_3390_ijms25126460 crossref_primary_10_1007_s12026_024_09500_w crossref_primary_10_1371_journal_pone_0265687 crossref_primary_10_15212_AMM_2022_0039 crossref_primary_10_1136_rmdopen_2023_003851 crossref_primary_10_47836_mjmhs_19_1_14 crossref_primary_10_1186_s13075_020_02252_6 crossref_primary_10_1007_s12026_023_09402_3 crossref_primary_10_3899_jrheum_2023_0907 crossref_primary_10_3389_fimmu_2023_1116435 crossref_primary_10_3389_fopht_2023_1106419 crossref_primary_10_3390_cells10113017 crossref_primary_10_3899_jrheum_220881 crossref_primary_10_1016_j_bios_2019_111642 crossref_primary_10_3389_fimmu_2020_01108 crossref_primary_10_1002_art_42463 crossref_primary_10_1111_iji_12643 crossref_primary_10_3389_fmed_2023_1129939 crossref_primary_10_1111_jcpe_13277 crossref_primary_10_3390_cancers13040591 crossref_primary_10_1111_joim_13058 crossref_primary_10_1136_rmdopen_2022_002511 crossref_primary_10_1136_rmdopen_2021_002099 crossref_primary_10_3389_fmed_2021_802934 crossref_primary_10_1097_BOR_0000000000001006 crossref_primary_10_1136_bmjopen_2020_048409 crossref_primary_10_17650_1818_8338_2022_16_3_K669 |
Cites_doi | 10.1016/j.cca.2014.05.019 10.1186/s13075-016-0940-2 10.1093/rheumatology/keu215 10.1002/art.11223 10.1002/art.39595 10.1155/2013/726598 10.1136/ard.2008.100677 10.1093/rheumatology/keg184 10.1186/1546-0096-11-31 10.1093/rheumatology/32.3.199 10.1136/ard.2010.138461 10.1186/s13075-017-1329-6 10.1186/1471-2105-12-77 10.1515/cclm-2017-0988 10.1038/nrrheum.2016.151 10.1016/j.autrev.2009.11.017 10.1007/s00393-016-0134-y 10.1136/annrheumdis-2016-209297 10.1002/art.39299 10.1038/nri.2016.124 10.1038/nrrheum.2017.15 10.1136/ard.2005.035691 |
ContentType | Journal Article |
Copyright | Copyright © 2018 Sieghart, Platzer, Studenic, Alasti, Grundhuber, Swiniarski, Horn, Haslacher, Blüml, Smolen and Steiner. 2018 Sieghart, Platzer, Studenic, Alasti, Grundhuber, Swiniarski, Horn, Haslacher, Blüml, Smolen and Steiner |
Copyright_xml | – notice: Copyright © 2018 Sieghart, Platzer, Studenic, Alasti, Grundhuber, Swiniarski, Horn, Haslacher, Blüml, Smolen and Steiner. 2018 Sieghart, Platzer, Studenic, Alasti, Grundhuber, Swiniarski, Horn, Haslacher, Blüml, Smolen and Steiner |
DBID | RYH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.3389/fimmu.2018.00876 |
DatabaseName | CiNii Complete CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-3224 |
ExternalDocumentID | oai_doaj_org_article_5e50788791d74227a4446da013909147 PMC5929149 29740454 10_3389_fimmu_2018_00876 |
Genre | Evaluation Studies Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Innovative Medicines Initiative Joint Undertaking grantid: 777357, 115142 |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD ACGFO ACGFS ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK EBS EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM RYH AAYXX ACXDI CITATION CGR CUY CVF ECM EIF IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c557t-7110f242672e5301006e8f913bb5a220e00bf7205d87a06d1fb40a72350b28993 |
IEDL.DBID | M48 |
ISSN | 1664-3224 |
IngestDate | Wed Aug 27 01:25:24 EDT 2025 Thu Aug 21 18:16:30 EDT 2025 Thu Sep 04 18:35:32 EDT 2025 Thu Apr 03 07:26:18 EDT 2025 Tue Jul 01 01:35:21 EDT 2025 Thu Apr 24 22:56:03 EDT 2025 Mon Aug 18 12:15:07 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | anti-citrullinated protein antibodies autoantibodies rheumatoid arthritis RA33 antibodies rheumatoid factor immunoglobulin isotypes |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c557t-7110f242672e5301006e8f913bb5a220e00bf7205d87a06d1fb40a72350b28993 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology These authors have contributed equally to this work. Edited by: Philippe Saas, INSERM UMR1098 Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique, France Reviewed by: Yasser El-Sherbiny, University of Leeds, United Kingdom; Willem Falkenburg, Sanquin, Netherlands |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2018.00876 |
PMID | 29740454 |
PQID | 2036787272 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5e50788791d74227a4446da013909147 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5929149 proquest_miscellaneous_2036787272 pubmed_primary_29740454 crossref_citationtrail_10_3389_fimmu_2018_00876 crossref_primary_10_3389_fimmu_2018_00876 nii_cinii_1871147691292693120 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-04-24 |
PublicationDateYYYYMMDD | 2018-04-24 |
PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-24 day: 24 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in Immunology |
PublicationTitleAlternate | Front Immunol |
PublicationYear | 2018 |
Publisher | Frontiers Media SA Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media SA – name: Frontiers Media S.A |
References | Malmstrom (B1) 2017; 17 Trouw (B20) 2016; 12 Nell-Duxneuner (B12) 2010; 69 Aletaha (B2) 2010; 69 Rantapaa-Dahlqvist (B3) 2003; 48 Ingegnoli (B17) 2013; 35 Falkenburg (B6) 2015; 67 Lee (B19) 2017; 76 Trouw (B23) 2017; 13 Cabrera-Villalba (B24) 2017; 19 Hajian-Tilaki (B15) 2013; 4 Falkenburg (B18) 2018 Conrad (B5) 2010; 9 Robin (B16) 2011; 17 Infantino (B8) 2014; 436 Bas (B4) 2003; 42 Nell (B11) 2005; 64 Gottenberg (B22) 2016; 68 Gilliam (B7) 2013; 11 Ball (B14) 2014; 53 Figueiredo (B21) 2017; 76 Brink (B9) 2016; 18 Hassfeld (B10) 1993; 32 Yang (B13) 2016; 34 |
References_xml | – volume: 436 start-page: 237 year: 2014 ident: B8 article-title: Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: an assessment of combined tests publication-title: Clin Chim Acta doi: 10.1016/j.cca.2014.05.019 – volume: 18 start-page: 43 year: 2016 ident: B9 article-title: Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis publication-title: Arthritis Res Ther doi: 10.1186/s13075-016-0940-2 – volume: 53 start-page: 1835 year: 2014 ident: B14 article-title: A study of erosive phenotypes in lupus arthritis using magnetic resonance imaging and anti-citrullinated protein antibody, anti-RA33 and RF autoantibody status publication-title: Rheumatology doi: 10.1093/rheumatology/keu215 – volume: 48 start-page: 2741 year: 2003 ident: B3 article-title: Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis publication-title: Arthritis Rheum doi: 10.1002/art.11223 – volume: 68 start-page: 1346 year: 2016 ident: B22 article-title: Brief report: association of rheumatoid factor and anti-citrullinated protein antibody positivity with better effectiveness of abatacept: results from the Pan-European Registry Analysis publication-title: Arthritis Rheumatol doi: 10.1002/art.39595 – volume: 35 start-page: 727 year: 2013 ident: B17 article-title: Rheumatoid factors: clinical applications publication-title: Dis Markers doi: 10.1155/2013/726598 – volume: 69 start-page: 169 year: 2010 ident: B12 article-title: Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study publication-title: Ann Rheum Dis doi: 10.1136/ard.2008.100677 – volume: 42 start-page: 677 year: 2003 ident: B4 article-title: Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis publication-title: Rheumatology doi: 10.1093/rheumatology/keg184 – volume: 11 start-page: 31 year: 2013 ident: B7 article-title: Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis publication-title: Pediatr Rheumatol Online J doi: 10.1186/1546-0096-11-31 – volume: 32 start-page: 199 year: 1993 ident: B10 article-title: Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis publication-title: Br J Rheumatol doi: 10.1093/rheumatology/32.3.199 – volume: 69 start-page: 1580 year: 2010 ident: B2 article-title: 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative publication-title: Ann Rheum Dis doi: 10.1136/ard.2010.138461 – volume: 19 start-page: 141 year: 2017 ident: B24 article-title: Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis publication-title: Arthritis Res Ther doi: 10.1186/s13075-017-1329-6 – volume: 17 start-page: 77 year: 2011 ident: B16 article-title: pROC: an open-source package for R and S+ to analyze and compare ROC curves publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-12-77 – year: 2018 ident: B18 article-title: Clinically relevant discrepancies between different rheumatoid factor assays publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2017-0988 – volume: 12 start-page: 566 year: 2016 ident: B20 article-title: Rheumatoid arthritis: autoantibody testing to predict response to therapy in RA publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2016.151 – volume: 9 start-page: 431 year: 2010 ident: B5 article-title: Profiling of rheumatoid arthritis associated autoantibodies publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2009.11.017 – volume: 76 start-page: 535 year: 2017 ident: B19 article-title: Diagnostic accuracy of anti-Sa and anti-RA33 antibodies in rheumatoid arthritis: a meta-analysis publication-title: Z Rheumatol doi: 10.1007/s00393-016-0134-y – volume: 76 start-page: 399 year: 2017 ident: B21 article-title: Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2016-209297 – volume: 34 start-page: 539 year: 2016 ident: B13 article-title: Diagnostic accuracy of anti-RA33 antibody for rheumatoid arthritis: systematic review and meta-analysis publication-title: Clin Exp Rheumatol – volume: 4 start-page: 627 year: 2013 ident: B15 article-title: Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation publication-title: Caspian J Intern Med – volume: 67 start-page: 3124 year: 2015 ident: B6 article-title: IgG subclass specificity discriminates restricted IgM rheumatoid factor responses from more mature anti-citrullinated protein antibody-associated or Isotype-switched IgA responses publication-title: Arthritis Rheumatol doi: 10.1002/art.39299 – volume: 17 start-page: 60 year: 2017 ident: B1 article-title: The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting publication-title: Nat Rev Immunol doi: 10.1038/nri.2016.124 – volume: 13 start-page: 331 year: 2017 ident: B23 article-title: Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2017.15 – volume: 64 start-page: 1731 year: 2005 ident: B11 article-title: Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis publication-title: Ann Rheum Dis doi: 10.1136/ard.2005.035691 |
SSID | ssj0000493335 |
Score | 2.4094567 |
Snippet | Anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) are the most commonly used diagnostic markers of rheumatoid arthritis (RA). These... |
SourceID | doaj pubmedcentral proquest pubmed crossref nii |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 876 |
SubjectTerms | Aged Anti-Citrullinated Protein Antibodies Anti-Citrullinated Protein Antibodies - blood Anti-Citrullinated Protein Antibodies - immunology Antibody Specificity Antibody Specificity - immunology Arthritis, Rheumatoid Arthritis, Rheumatoid - blood Arthritis, Rheumatoid - diagnosis Arthritis, Rheumatoid - immunology autoantibodies Case-Control Studies Diagnostic Tests, Routine Diagnostic Tests, Routine - methods Female Healthy Volunteers Humans immunoglobulin isotypes Immunoglobulin Isotypes - blood Immunoglobulin Isotypes - immunology Immunologic diseases. Allergy Immunology Male Middle Aged RA33 antibodies RC581-607 rheumatoid arthritis rheumatoid factor Rheumatoid Factor - blood Rheumatoid Factor - immunology Sensitivity and Specificity Serologic Tests Serologic Tests - methods |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELaqSki9IB4FAhQZqRcO0Tp-xMmxPKqCRA-FSr1ZdmxrA22C2M2h_54Ze3e1i6py4bKK8tB6Z8ae71tPviHk2FcO0jx4oGPBl9JJXloPLEVbXovIeGhT_5Sv5_XZpfxypa62Wn1hTViWB86Gm6kAiAVmQlt5YHFcWwkExltELpDqZHqPnLVsi0z9yLhXCKHyviSwsHYW-5ubCUu5sHayQYmRrTyU5Pohuwx9fxfS_LtgcisDnT4iD1fQkZ7kIT8me2F4Qh7kZpK3T8nPj-vKFrQ1HSM9mZYjGK53o7-lnxcj_t26oLAiYCE6HAH2o9-wgD13kMBHYOkYfa6-Q_1m2g_0Yh4mgLVj7_Gr50kE6ZBcnn76_uGsXLVSKDul9LLUkOUjZmPNg4I5DXMtNLGthHPKcs4CYy5qzpRvtGW1r6KTzGouFHNIycQzsj-MQ3hBaFN1SDp8jLqTtoXrQQsHKEyyxqraFWS2NqzpVjrj2O7i2gDfQFeY5AqDrjDJFQV5t3niV9bYuOfe9-irzX2ojp1OQMyYVcyYf8VMQY7A0zA6_KyAMsK5ugXkw-tWVJwV5O06BgzMNtxCsUMYp4XBbVtY4rjmBXmeY2IzFA7UDAUNC6J3omVnrLtXhn6eFL0VgFSgqi__x497RQ7QXLjjxeVrsr_8PYUjAE5L9ybNkT8EmxEB priority: 102 providerName: Directory of Open Access Journals |
Title | Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis |
URI | https://cir.nii.ac.jp/crid/1871147691292693120 https://www.ncbi.nlm.nih.gov/pubmed/29740454 https://www.proquest.com/docview/2036787272 https://pubmed.ncbi.nlm.nih.gov/PMC5929149 https://doaj.org/article/5e50788791d74227a4446da013909147 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagCIkLojwDtDISFw6hjh_x5oBQaSkFqRyAlfZm2bHTTWlj2N1I7L9nJsluWbSCSxQ5tmLNeDzfF09mCHnpMwduHjRQsuBT6SRPrQeWoi3PRcV4KLr6KWef89Ox_DRRk-vfowcBzrdSO6wnNZ5dvv71c_kWDP4NMk7wtwdVfXXVYpQWhkWCdd8kt8Av5UjFzgawf9FjYSGE6s8qtw7c8E1dCn_wOE1db0OffwdR_uGVTu6RuwOcpIe9_nfJjQt7n9zuC0wuH5Dvx6toF5Q_jRU9bBcRhFm76Jf04zziJ9g5hV0Cg9PhDvAg_YpB7X1VCRwC20n0fUQe5nSmdUO_TEMLUDfWHl897RIjPSTjk_ffjk7TobxCWiqlF6kGz1-hh9Y8KLBzsL8wqopMOKcs5yww5irNmfIjbVnus8pJZjUXijmkaeIR2WliE54QOspKJCK-qnQpbQHPgxYOkJlkI6tyl5CDlWBNOeQexxIYlwY4CKrCdKowqArTqSIhr9YjfvR5N_7R9x3qat0PM2Z3DXF2bgYDNCoA8oUdtci8lpxrK4EIe4sIGCCT1AnZA03D7PCaAY2EtrwANMTzQmScJeTFag0YsEA8VrFNiO3c4FEubHtc84Q87tfEeioc6BomOUyI3lgtG3PdfNLU0y7LtwLgCvT16X_m9YzcQUngAReXz8nOYtaGPcBJC7fffV-A64dJtt-Zwm8v7A6- |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determination+of+Autoantibody+Isotypes+Increases+the+Sensitivity+of+Serodiagnostics+in+Rheumatoid+Arthritis&rft.jtitle=Frontiers+in+Immunology&rft.au=Sieghart&rft.au=Daniela%3B+Platzer&rft.au=Alexander%3B+Studenic&rft.au=Paul%3B+Alasti&rft.date=2018-04-24&rft.pub=Frontiers+Media+SA&rft.eissn=1664-3224&rft.volume=9&rft_id=info:doi/10.3389%2Ffimmu.2018.00876 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |